about
Mutations in NR5A1 associated with ovarian insufficiencyDominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism.Bone metastases from differentiated thyroid carcinoma.Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives.Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).Pragmatic diabetes management in nursing homes: individual care plan.Endocrine disorders in Woodhouse-Sakati syndrome: a systematic review of the literature.Usefulness of bone density measurement in fallers.Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis.2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis.Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives.Trabecular Bone Score: Where are we now?Efficacy and safety of denosumab for the treatment of osteoporosis: A systematic review.Thyroid side effects prophylaxis in front of nuclear power plant accidents.Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations.Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism.[Bone and androgens].Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.Long-term prognosis of patients with pediatric pheochromocytoma.A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.McCune-Albright syndrome, natural history and multidisciplinary management in a series of 14 pediatric cases.Clinical audit concerning the quality of management in patients with classic form of congenital adrenal hyperplasia.Assessment of determinants for osteoporosis in elderly men.Robotic-assisted adrenalectomy: what advantages compared to lateral transperitoneal laparoscopic adrenalectomy?Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas.Treatment of osteoporosis in menClinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?Severe hypoglycemia with “Big”-IGF-2 oversecretion by a giant phyllode tumor of the breast: A rare case of non-islet cell tumor-induced hypoglycemia (NICTH)Effects of denosumab on bone turnover markers in postmenopausal osteoporosisTissue Factor Pathway InhibitorHigher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d’étude des Tumeurs Endocrines (GTE) cohort study[The thyroid nodules revisited]Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma[Evaluation of theoretical teaching of the French diploma of medical gynecology][Azoospermia and 45,X/46,XY chromosomal mosaicism: a case report][HAS report on vitamin D measurement: don't go from an extreme situation to another as extreme situation][Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement][An adult patient with 49, XXXXY syndrome: further clinical and biological delineation]VEGF-A is associated with early degenerative changes in cartilage and subchondral bone
P50
Q24655709-E6B71091-A9C5-4A34-9B0D-DCD1B37AAF83Q36938300-3E928C00-2DA6-44F7-A73B-05F654AF021DQ37098297-3A874641-2C31-4173-A8E0-E557B9477ADCQ37150012-74C9F1F8-EDE1-44E9-81C6-79E20FC1B2DBQ38074186-B8BAB77F-9CE3-4F12-A490-314F47628372Q38151440-BBE2D135-8350-4CD1-81B9-E61F1E316281Q38181990-511B5B0C-FD8E-4B11-98D0-6C126D5A7A0AQ38202338-2F7C5AAA-453E-4822-A427-2D1CD1B6E45DQ38216228-79108C9D-718C-4988-9A81-4F5B61D67E51Q38278555-AFFF6649-F8DA-4FF1-81FA-C45ED46DDAF3Q38306336-61E8EB40-9244-4140-941D-7BBAE655DA18Q38447807-F2959F91-F497-4047-AEC0-A89D26DEB8FCQ38660154-917563D9-C5DD-4CA6-85A1-4402CA423705Q38718242-D498C8A8-55CA-4A9C-AD28-2DFE127FE337Q42655520-5831856B-F8B8-44DF-896F-289E9C79FC0FQ43059511-CD57296A-7822-41EE-8DFD-FE2E9CC091CDQ43230567-3806E20B-AE2F-4E98-B64D-2ABCF10A7AB2Q43801140-AF6EFD04-E9D1-4691-A6BB-29B39EB2BD3DQ44476584-AD85DEBC-F95E-4477-AB46-34010875A9F3Q45956828-5F45FF19-E86E-41B8-BC5D-9E2E8F95EFECQ46715143-F3AA12B1-404C-4B61-AF39-C675D1D8B64BQ47833942-DD62394D-09E6-45DA-A655-FC0D85FE7F65Q50876506-C905557A-7FFA-4DDC-908B-49310294D7C3Q51863174-22089743-F48B-4CC4-9B7A-EC74ACF8B3D8Q51892110-BEB9CE77-B23B-47BE-97A6-15890E9F8EF0Q54386880-99D5417D-79D5-443F-BF48-ED9E9A5B6A15Q56109539-9C515B23-1F53-43A9-AA08-9FB451F64629Q57765048-0907A4AA-28FD-49A0-AA68-37C61DA28C82Q57765064-555D87B1-CD40-4287-81B9-282D72DDB765Q58970691-69D486F1-AB19-45FD-8D77-7C96BE3AA50DQ59275517-7C94768F-9157-4E61-A9F5-1855EEB09C9CQ61647410-103357DE-839B-497B-B054-FBE9C27C40CFQ83928394-3C7905BA-2629-44BF-AAA6-154C97A877F6Q86130664-BAB28D72-0F7D-406C-A3E7-839272747CD4Q86208750-551FFE64-D86A-4A4C-B803-BBEB2816A70BQ86405894-9DB6C973-B8B0-4B11-81E8-4D3117F80400Q87120692-C98607E8-4E28-453D-91B5-1B574E029834Q87567669-233D0C21-0099-4F24-AF13-2DB60E8D6F02Q87981446-9CBA5585-71EF-4F6F-B18F-27A35B02367AQ91588366-A7BE4A52-7DFD-485B-A07F-890382BC0FE5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Georges Weryha
@ast
Georges Weryha
@en
Georges Weryha
@es
Georges Weryha
@nl
type
label
Georges Weryha
@ast
Georges Weryha
@en
Georges Weryha
@es
Georges Weryha
@nl
prefLabel
Georges Weryha
@ast
Georges Weryha
@en
Georges Weryha
@es
Georges Weryha
@nl
P106
P31
P496
0000-0003-2062-3419